The receptiveness toward remotely supported myofeedback treatment

M.H.A. Huis in 't Veld, Gerlienke Voerman, Hermanus J. Hermens, Miriam Marie Rosé Vollenbroek-Hutten

    Research output: Contribution to journalArticleAcademicpeer-review

    6 Citations (Scopus)


    Remotely supported myofeedback treatment (RSMT) is considered to be a potentially valuable alternative to the conventional myofeedback treatment, as it might increase efficiency of care. This study was aimed at examining the receptiveness of potential end users (patients and professionals) with respect to RSMT. By doing so, protocols of RSMT can be developed which fit to the needs of end users and enhance treatment adherence. For both end-user groups, questionnaires were developed focusing on two components of the attitude–social support–self-efficacy (ASE) model. Fifteen patients with neck–shoulder complaints previously treated with conventional myofeedback and 17 professionals participated in the study. Results showed positive attitudes toward RSMT in 53% of the patients, and 67% of them were willing to participate in RSMT. Of the 17 professionals included in the present study 43% reported a positive attitude. In addition, 40% of the patients and 100% of the professionals believed their self-efficacy level to be sufficient for RSMT. In addition to e-consultations, 40% percent of the patients suggested that the optimal frequency of structural in vivo contact with their therapist would be once per 2 weeks, which is less frequent compared to the weekly in vivo contacts in the conventional myofeedback treatment. Professionals emphasized the importance of nonverbal communication and physical interaction (as in in vivo contact) in remote treatment concepts.
    Original languageUndefined
    Article number10.1089/tmj.2006.0041
    Pages (from-to)293-302
    Number of pages10
    JournalTelemedicine and e-health
    Issue number3
    Publication statusPublished - Jan 2007


    • BSS-Biomechatronics and rehabilitation technology
    • EWI-11772
    • METIS-247096
    • IR-62130

    Cite this